![](/img/cover-not-exists.png)
242PDSubgroup analysis of Asian men in the PREVAIL trial of enzalutamide (ENZA) in men with chemotherapy-naïve, metastatic castration-resistant prostate cancer (mCRPC)
Kim, C.-S., Choi, Y.D., Lee, S.E., Lee, H.M., Ueda, T., Yonese, J., Fukagai, T., Chiong, E., Lau, W., Abhyankar, S., Theeuwes, A., Tombal, B., Beer, T.M., Kimura, G.Volume:
26
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdv524.07
Date:
December, 2015
File:
PDF, 38 KB
english, 2015